BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 18706978)

  • 1. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
    Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
    Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis: a primary pathology of astrocytes?
    Sosunov AA; Wu X; Weiner HL; Mikell CB; Goodman RR; Crino PD; McKhann GM
    Epilepsia; 2008; 49 Suppl 2():53-62. PubMed ID: 18226172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential distribution of group I metabotropic glutamate receptors in developing human cortex.
    Boer K; Encha-Razavi F; Sinico M; Aronica E
    Brain Res; 2010 Apr; 1324():24-33. PubMed ID: 20149785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
    Boer K; Jansen F; Nellist M; Redeker S; van den Ouweland AM; Spliet WG; van Nieuwenhuizen O; Troost D; Crino PB; Aronica E
    Epilepsy Res; 2008 Jan; 78(1):7-21. PubMed ID: 18023148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia.
    Aronica E; Gorter JA; Jansen GH; van Veelen CW; van Rijen PC; Ramkema M; Troost D
    Epilepsia; 2003 Jun; 44(6):785-95. PubMed ID: 12790891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
    Geurts JJ; Wolswijk G; Bö L; van der Valk P; Polman CH; Troost D; Aronica E
    Brain; 2003 Aug; 126(Pt 8):1755-66. PubMed ID: 12805104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
    Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
    Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
    Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
    Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
    Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
    Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
    Miyata H; Chiang AC; Vinters HV
    Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
    Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
    Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
    Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
    Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
    Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
    Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex.
    Marcotte L; Aronica E; Baybis M; Crino PB
    Acta Neuropathol; 2012 May; 123(5):685-93. PubMed ID: 22327361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
    Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
    Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of cellular proliferation are expressed in cortical tubers.
    Lee A; Maldonado M; Baybis M; Walsh CA; Scheithauer B; Yeung R; Parent J; Weiner HL; Crino PB
    Ann Neurol; 2003 May; 53(5):668-73. PubMed ID: 12731003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of metabotropic glutamate receptors in rat dorsal root ganglion cells.
    Carlton SM; Hargett GL
    J Comp Neurol; 2007 Apr; 501(5):780-9. PubMed ID: 17299761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Ess KC; Kamp CA; Tu BP; Gutmann DH
    Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.